Review: Retinoids in cancer prevention and therapy

Annals of Oncology

Volumn 3, Issue 7, 1992, Pages 513-526

  Bollag, W ^a   Holdener, E E ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Cancer prevention; Cancer therapy; Combination therapy; Cytokines; Mechanism of action; Retinoids

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; ETRETIN; ETRETINATE; ISOTRETINOIN; RECOMBINANT ALPHA2A INTERFERON; RETINOIC ACID; RETINOID; RO 13 6307; RO 14 6113; TEMAROTENE; UNCLASSIFIED DRUG;

CANCER; CANCER PREVENTION; CANCER THERAPY; DRUG MECHANISM; HUMAN; REVIEW;

EID: 0026750804     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a058252     Document Type: Review

References (175)

1. Y. Fujimaki Formation of carcinoma in albino rats fed on deficient diets J Cancer Res 10 1926 469 477
2. S. Mori The changes in the para-ocular glands which follow the administration of diets low in fat-soluble A; with notes on the effect of the same diets on the salivary glands and the mucosa of the larynx and trachea Bull Johns Hopkins Hosp 33 1922 357 359
3. S.B. Wolbach P.R. Howe Tissue changes following deprivation of fat-soluble A-vitamin J Exp Med 42 1925 753 778
4. S.B. Wolbach P.R. Howe Vitamin A deficiency in the guineapig Arch Pathol 5 1928 239 253
5. E.W. Chu R.A. Malmgren An inhibitory effect of vitamin A on the induction of tumors of forestomach and cervix in the Syrian hamster by carcinogenic polycyclic hydrocarbons Cancer Res 25 1965 884 895
6. R.E. Davies Effect of vitamin A on 7, 12-dimethylbenz(a)-anthracene-induced papillomas in Rhino mouse skin Cancer Res 27 1967 237 241
7. I. Lasnitzki Growth pattern of the mouse prostate gland in organ culture and its response to sex hormones, vitamin A and 3-methyl-cholanthrene Natl Cancer Inst Monogr 12 1963 381 403
8. N.A. Rowe R.J. Gorlin The effect of vitamin A deficiency upon experimental carcinogenesis J Dent Res 38 1959 72 83
9. U. Saffiotti R. Montesano A.R. Sellakumar Experimental cancer of the lung Inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous cell tumors. Cancer 20 1967 857 864
10. W. Bollag Vitamin A and vitamin A acid in the prophylaxis and therapy of epithelial tumours Internat J Vit Res 40 1970 299 314
11. W. Bollag Therapy of chemically induced skin tumors of mice with vitamin A palmitate and vitamin A acid Experientia 27 1971 90 92
12. W. Bollag Effects of vitamin A acid on transplantable and chemically induced tumors Cancer Chemother Rep 55 1971 53 58
13. W. Bollag Prophylaxis of chemically induced benign and malignant epithelial tumors by vitamin A acid (retinoic acid) Eur J Cancer 8 1972 689 693
14. W. Bollag Therapeutic effects of an aromatic retinoic acid analog on chemically induced skin papillomas and carcinomas of mice Eur J Cancer 10 1974 731 737
15. W. Bollag Prophylaxis of chemically induced epithelial tumors with an aromatic retinoic acid analog (Ro 10-9359) Eur J Cancer 11 1975 721 724
16. W. Bollag Arotinoids, a new class of retinoids with activities in oncology and dermatology Cancer Chemother Pharmacol 7 1981 27 29
17. W. Bollag Vitamin A and retinoids: From nutrition to pharmacotherapy in dermatology and oncology Lancet 1 1983 860 863
18. W. Bollag The development of retinoids in experimental and clinical oncology and dermatology J Am Acad Dermatol 9 1983 797 805
19. W. Bollag New retinoids with potential use in humans J.H. Saurat Retinoids, New Trends in Research and Therapy 1985 Karger Basel 274 290
20. W. Bollag H.R. Hartmann Prevention and therapy of cancer with retinoids in animals and man Cancer Surv 2 1983 293 314
21. I. Lasnitzki W. Bollag Prevention and reversal by a non-polar arotinoid (Ro 15-0778) of 3,4-benzpyrene- and cigarette smoke condensate-induced hyperplasia and metaplasia of rodent respiratory epithelia grown in vitro Eur J Cancer Clin Oncol 23 1987 861 865
22. H. Mayer W. Bollag R. Hanni Retinoids, a new class of compounds with prophylactic and therapeutic activities in oncology and dermatology Experientia 34 1978 1105 1119
23. R.C. Moon L.M. Itri Retinoids and cancer In Sporn MB, Roberts AB, Goodman DS (eds): The Retinoids. Orlando: Academic Press 2 1984 327 371
24. R.C. Moon R.G. Mehta D.L. McCormick Suppression of mammary cancer by retinoids R.G. Crispen Cancer Etiology and Prevention 1983 Elsevier Amsterdam 275 340
25. M.B. Sporn N.M. Dunlop D.L. Newton Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs Fed Proc 35 1976 1332 1338
26. M.B. Sporn R.A. Squire C.C. Brown 13-cis-retinoic acid Inhibition of bladder carcinogenesis in the rat. Science 195 1977 487 489
27. K. Teelmann W. Bollag Therapeutic effect of the arotinoid Ro 15-0778 on chemically induced rat mammary carcinoma Eur J Cancer Clin Oncol 24 1988 1205 1209
28. A. Schumacher G. Stüttgen Vitamin A-Säure bei Hyperkeratosen, epithelialen Tumoren and Akne Dtsch Med Wchnschr 40 1971 1547 1551
29. S.M. Lippman J.F. Kessler F.L. Meyskens Retinoids as preventive and therapeutic anticancer agents (Part II) Cancer Treatm Rep 71 1987 493 515
30. S.M. Lippman F.L. Meyskens Results of the use of vitamin A and retinoids in cutaneous malignancies Pharmac Ther 40 1989 107 122
31. R. Blomhoff M.H. Green T. Berg Transport and storage of vitamin A Science 250 1990 399 404
32. F. Chytil D.E. Ong Cellular retinoid-binding proteins M.B. Sporn A.B. Roberts D.S. Goodman The Retinoids 1984 Academic Press Orlando-Sao Paulo 90 320
33. D. Benbrook E. Lernhardt M. Pfahl A new retinoic acid receptor identified from a hepatocellular carcinoma Nature 333 1988 669 672
34. N. Brand M. Petkovich A. Krust Identification of a second human retinoic acid receptor Nature 332 1988 850 853
35. V. Giguere E.S. Ong P. Segui Identification of a receptor for the morphogen retinoic acid Nature 330 1987 624 629
36. A. Krust P.h. Kastner M. Petkovich A third human retinoic acid receptor, hRAR-γ Proc Natl Acad Sci USA 86 1989 5310 5314
37. M. Petkovich N.J. Brand A. Krust A human retinoic acid receptor which belongs to the family of nuclear receptors Nature 330 1987 444 450
38. C.W. Ragsdale M. Petkovich P.B. Gates Identification of a novel retinoic acid receptor in regenerative tissues of the newt Nature 341 1989 654 657
39. A. Zelent A. Krust M. Petkovich Cloning of murine α and β retinoic acid receptor and a novel receptor γ predominantly expressed in skin Nature 339 1989 714 717
40. D.J. Mangelsdorf E.S. Ong J.A. Dyck Nuclear receptor that identifies a novel retinoic acid response pathway Nature 345 1990 224 229
41. V.C. Yu C. Delsert B. Andersen RXRβ A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements Cell 67 1991 1251 1266
42. X.K. Zhang B. Hoffmann P.B. Tran Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors Nature 355 1992 441 446
43. 3 signalling Nature 355 1992 446 449
44. D.J. Mangelsdorf K. Umesono S.A. Kliewer A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR Cell 66 1991 555 561
45. A.A. Levin L.J. Sturzenbecker Kazmer 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα Nature 355 1992 359 361
46. R.A. Heyman D.J. Mangelsdorf J.A. Dyck 9-CIS retinoicacid is a high affinity ligand for the retinoid X receptor Cell 68 1992 397 406
47. M. Leid P. Kastner R. Lyons Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently Cell 68 1992 377 395
48. T.R. Breitman B.R. Keene H. Hemmi Retinoic acid-induced differentiation of fresh human leukaemia cells and the human myelomonocytic leukaemia cell lines, HL-60, U-937 and THP–1 Cancer Surv 2 1983 263 291
49. T.R. Breitman S.E. Selonick S.J. Collins Induction of differentiation of the human promyelocytic leukemia cell lines (HL-60) by retinoic acid Proc Natl Acad Sci USA 77 1980 2936 2940
50. F.R. Balkwill F. Burke The cytokine network Immunol Today 10 1989 299 303
51. C. Chomienne N. Balitrand H. Cost Structure-activity relationships of aromatic retinoids on the differentiation of the human histiocytic lymphoma cell line U-937 Leukemia Res 10 1986 1301 1305
52. N. Sidell Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro J Natl Cancer Inst 68 1982 589 593
53. S. Strickland V. Mahdavi The induction of differentiation in teratocarcinoma stem cells by retinoic acid Cell 15 1978 393 403
54. M.I. Sherman K.I. Matthaei J. Schindler Studies on the mechanism of induction of embryonal carcinoma cell differentiation by retinoic acid Ann NY Acad Sci 359 1981 192 199
55. R. Lotan Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells Biochim Biophys Acta 605 1980 33 91
56. A.B. Roberts M.B. Sporn Cellular biology and biochemistry of the retinoids M.B. Sporn A.B. Roberts D.S. Goodman The Retinoids 1984 Academic Press Orlando-Sao Paulo 209 560
57. B.J. Nickoloff T.Y. Basham T.C. Merigan Immunomodulatory and antiproliferative effect of recombinant alpha, beta and gamma interferons on cultured human malignant squamous cell lines, SCL-1 and SW-1271 J Invest Dermatol 84 1985 487 490
58. I.L. Olsson T.R. Breitman Induction of differentiation of the human histiocytic lymphoma cell line U–937 by retinoic acid and cyclic adenosine 3': 5'-monophosphate-inducing agents Cancer Res 42 1982 3924 3927
59. A.M. Jetten Induction of differentiation of embryonal carcinoma cells by retinoids M.I. Sherman Retinoids and Cell Differentation 1986 CRC Press Boca Raton, Florida 105 590
60. A.M. Jetten M.E.R. Jetten M.I. Sherman Stimulation of differentiation of several murine embryonal carcinoma cell lines by retinoic acid Exp Cell Res 124 1979 381 391
61. M.E. Huang Y.C. Ye S.R. Chen Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia Blood 72 1988 567 572
62. S. Castaigne C. Chomienne M.T. Daniel All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia I. Clinical results. Blood 76 1990 1704 1709
63. L. Degos C. Chomienne M.T. Daniel Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid Lancet 2 1990 1440 1441
64. R.P. Warrell S.R. Frankel W.H. Miller Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid) N Engl J Med 324 1991 1385 1393
65. P. Fenaux S. Castaigne H. Dombret All-trans retinoic acid (ATRA) as first line therapy of acute promyelocytic leukemia (APL) A report on 44 cases. Haematologica 76 Suppl 4 1991 N 60
66. S. Frankel M. Weiss R.P. Warrell A 'retinoic acid syndrome' in acute promylocytic leukemia: Reversal by corticosteroids Blood 78 Suppl 1 1991 1511
67. Z.X. Chen Y.Q. Xue R. Zhang A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients Blood 78 1991 1413 1419
68. R.P. Warrell S.R. Frankel W.H. Miller Clinical, pharmacologic and molecular aspects of all-trans retinoic acid treatment in acute promyelocytic leukemia Retinoids 1991 New Trends in Research and Clinical Applications Symposiu
69. Z. Chen G.L. Sun S.J. Chen All-trans retinoic acid and acute promyelocytic leukemia (APL) in China: From clinic to molecular biology Retinoids 1991 New Trends in Research and Clinical Applications Symposiu
70. L. Degos S. Castaigne P. Fenaux All-trans retinoic acid in acute promyelocytic leukemia From clinical results to molecular biology. Haematologica 76 Suppl 4 1991 N 55
71. G. Avvisati M.C. Petti A. Spadea All-trans retinoic acid (RA) in poor risk acute promyelocytic leukemia (APL): A pilot study of the Italian cooperative group GIMEMA Haematologica 76 Suppl 4 1991 N 56
72. R. Ohno T. Ohshima H. Dohi All-trans retinoic acid as a differentiation therapy for refractory acute promyelocytic leukemia (APL) Haematologica 76 Suppl 4 1991 N 152
73. R. Peck W. Bollag Potentiation of retinoid-induced differentiation of HL-60 and U937 cell lines by cytokines Eur J Cancer 27 1991 53 57
74. W. Bollag R. Peck Modulation of growth and differentiation by retinoids and cytokines J.H. Saurat Retinoids: 10 years on 1991 Karger Basel 127 740
75. C. Apfel M. Crettaz G. Siegenthaler Synthetic retinoids: Binding to RAR J.H. Saurat Retinoids: 10 years on 1991 Karger Basel 110 750
76. P.B. Fisher S. Grant Effects of interferon on differentiation of normal and tumor cells Pharmac Ther 27 1985 143 166
77. M. Tomida Y. Yamamoto M. Hozumi Stimulation by interferon of induction of differentiation of human promyelocytic leukemia cells Biochem Biophys Res Commun 104 1982 30 37
78. H. Hemmi T.R. Breitman Combinations of recombinant human interferons and retinoic acid synergistically induce differentiation of the human promyelocytic leukemia cell line HL-60 Blood 69 1987 501 507
79. E.A. Kohlhepp M.E. Condon A.W. Hamburger Recombinant human interferon α enhancement of retinoic acid-induced differentiation of HL-60 cells Exp Hematol 15 1987 414 418
80. G. Trinchieri M. Rosen B. Perussia Retinoic acid cooperates with tumor necrosis factor and immune interferon in inducing differentiation and growth inhibition of the human promyelocytic leukemic cell line HL-60 Blood 69 1987 1218 1224
81. C.K. Ho Synergistic anticellular effect of a combination of β-interferon and retinoic acid against U937 cells Cancer Res 45 1985 5348 5351
82. V. Santini R. Delwel B. Lowenberg Terminal granulocytic maturation in acute myeloid leukemia (AML) following granulocyte colony stimulating factor (G-CSF) and retinoic acid (RA) stimulation Exp Hematol 17 1989 646
83. T. Nakamaki A. Sakashita M. Sano Granulocyte-colony stimulating factor and retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells in vitro Jpn J Cancer Res 80 1989 1077 1082
84. J.R. Frey R. Peck W. Bollag Antiproliferative activity of retinoids, interferon α and their combination in five human transformed cell lines Cancer Letters 57 1991 223 227
85. W. Bollag R. Peck J.R. Frey Inhibition of proliferation by retinoids, cytokines and their combination in four human transformed epithelial cell lines Cancer Letters 62 1992 167 172
86. A.M. Jetten J.S. Kim P.G. Sacks Inhibition of growth and squamous cell differentiation markers in cultured human head and neck squamous carcinoma cells by β-all-trans retinoic acid Int J Cancer 45 1990 195 202
87. M. Ponec A. Weerheim J. Kempenaar Proliferation and differentiation of human squamous carcinoma cell lines and normal keratinocytes: Effects of epidermal growth factor, retinoids and hydrocortisone In Vitro Cell Dev Biol 24 1988 764 770
88. P.G. Sacks V. Oke B. Amos Modulation of growth, differentiation and glycoprotein synthesis by β-all-trans retinoic acid in a multicellular tumor spheroid model for squamous cell carcinoma of the head and neck Int J Cancer 44 1989 926 933
89. C. Marth G. Daxenbichler O. Dapunt Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells J Natl Cancer Inst 77 1986 1197 1202
90. C. Marth P. Kirchebner G. Daxenbichler The role of polyamines in interferon and retinoic acid mediated synergistic antiproliferative action Cancer Letters 44 1989 55 59
91. O. Braun-Falco A. Galosi M. Dorn Tumorprophylaxe bei Xeroderma pigmentosum mit aromatischem Retinoid (Ro 10-9359) Hautarzt 33 1982 445 448
92. K.H. Kraemer J.J. DiGiovanna A.N. Moshell Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin N Engl J Med 318 1988 1633 1637
93. E. Pichler P. Fritsch Xeroderma Pigmentosum: Tumorprophylaxe mit Etretinat Hautarzt 35 1984 159 161
94. L. Schnitzler Rétinoides et prévention des épithéliomas cutanes: 1977–1987 Ann Dermatol Venereol 114 1987 1537 1543
95. G.L. Peck Therapy and prevention of skin cancer J.H. Saurat Retinoids, New Trends in Research and Therapy 1985 Karger Basel 345 950
96. G.L. Peck J.J. DiGiovanna D.S. Sarnoff Treatment and prevention of basal cell carcinoma with oral isotretinoin J Am Acad Dermatol 19 1988 176 185
97. J.W. Kelly J. Sabto F.W. Gurr Retinoids to prevent skin cancer in organ transplant recipients Lancet 2 1991 1407
98. O. Alfthan J. Tarkkanen P. Gröhn Tigason (etretinate) in prevention of recurrence of superficial bladder tumors Eur Urol 9 1983 6 9
99. U.E. Studer C. Biedermann D. Chollet Prevention of recurrent superficial bladder tumors by oral etretinate: Preliminary results of a randomized, double blind multicenter trial in Switzerland J Urol 131 1984 47 49
100. W.K. Hong S.M. Lippman L.M. Itri Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck N Engl J Med 323 1990 795 801
101. J.C. Belisario Recent advances in topical cytotoxic therapy of skin cancer and pre-cancer Melanoma and Skin Cancer. Proceedings International Cancer Conference 1972 349 365
102. W. Bollag F. Ott Therapy of actinic keratoses and basal cell carcinomas with local application of vitamin A acid Cancer Chemotherapy Rep 55 1971 59 60
103. G. Stüttgen Zur Lokalbehandlung von Keratosen mit Vitamin A-Säure Dermatologica 124 1962 65 80
104. C. Grupper B. Berretti Cutaneous neoplasia and etretinate K.H. Spitzy K. Karrer Proceedings 13th International Congress of Chemotherapy 1983 Egermann Vienna 24 1040
105. M. Moriarty J. Dunn A. Darragh Etretinate in treatment of actinic keratosis: A double blind crossover study Lancet 1 1982 364 365
106. A.B. Watson Preventative effect of etretinate therapy on multiple actinic keratoses Cancer Detect Prev 9 1986 161 165
107. R.P. Haydey M.L. Reed L.M. Dzubow Treatment of keratoacanthomas with oral 13-cis-retinoic acid N Engl J Med 303 1980 560 562
108. N. Levine R.C. Miller F.L. Meyskens Oral isotretinoin therapy: Use in a patient with multiple cutaneous squamous cell carcinomas and keratoacanthomas Arch Dermatol 120 1984 1215 1217
109. J.C. Shaw C.R. White Treatment of multiple keratoacanthomas with oral isotretinoin J Am Acad Dermatol 15 1986 1079 1082
110. M. Cristofolini F. Piscioli G. Zumiani The role of etretinate (Tegison, Tigason) in the management of keratoacanthoma J Am Acad Dermatol 12 1985 633 638
111. H. Mensing G. Wagner Etretinat-Therapie bei solitären Keratoakanthomen Zschr Hautkr 63 1988 234 236
112. Y. Edelson B. Berretti C. Grupper Retinoids, Advances in Basic Research and Therapy 1981 Springer Springer 446
113. J.J. Guilhou S. Malbos S. Barneon Epidermodysplasie verruciforme (2 observations) Etude Immunologique. Ann Dermatol Venereol 107 1980 611 619
114. S. Jablonska S. Obalek H. Wolska Ro 10-9359 in epidermodysplasia verruciformis: Preliminary report C.E. Orfanos O. Braun-Falco E.M. Farber Retinoids, Advances in Basic Research and Therapy 1981 Springer Berlin 401 1140
115. L.O. Kanerva E. Johansson K.M. Niemi Epidermodysplasia verruciformis Clinical and light- and electron-microscopic observations during etretinate therapy. Arch Dermatol Res 278 1985 153 160
116. M.A. Lutzner C. Blanchet-Bardon Oral retinoid treatment of human papillomavirus type 5-induced epidermodysplasia verruciformis N Engl J Med 302 1980 1091
117. H.J. Ryssel K.W. Brunner W. Bollag Die perorale Anwendung von Vitamin A-Säure bei Leukoplakien, Hyperkeratosen und Plattenepithelkarzinomen: Ergebnisse und Verträglichkeit Schweiz Med Wochenschr 101 1971 1027 1030
118. W.K. Hong J. Endicott L.M. Itri 13-cis retinoic acid in the treatment of oral leukoplakia N Engl J Med 315 1986 1501 1505
119. H.F. Koch Biochemical treatment of precancerous oral lesions: The effectiveness of various analogues of retinoic acid J Maxillofac Surg 6 1978 59 63
120. H.F. Koch Effect of retinoids on precancerous lesions of oral mucosa C.E. Orfanos O. Braun-Falco E.M. Farber Retinoids, Advances in Basic Research and Therapy 1981 Springer Berlin 307 1200
121. H. Koch D. Schettler Klinische Erfahrungen mit Vitamin A-Säure-Derivaten bei der Behandlug von Leukoplakien der Mundschleimhaut Dtsch zahnärztl Zschr 28 1973 623 627
122. P.A. Ehrl Klinische Untersuchung einer aromatischen Retinoids (Ro 10-9359) zur Behandlung oraler Hyperkeratosen Dtsch zahnärztl Zschr 35 1980 554 558
123. E. Bichler Treatment of pachydermias of the larynx with aromatic retinoid K.H. Spitzy K. Karrer Proceedings 13th International Congress of Chemotherapy 1983 Egermann Vienna 13 1230
124. E. Bichler H. Rauchegger Behandlung von Larynxpachydermien mit aromatischem Retinoid (Ro 10–9359); weitere Ergebnisse HNO 30 1982 290 292
125. E. Bichler H. Spöndlin Behandlung von Larynxpachydermien mit aromatischem Retinoid (Ro 10–9359) Arch Oto-Rhino-Laryngol 225 1979 9 14
126. D.S. Alberts S.W. Coulthard F.L. Meyskens Regression of aggressive laryngeal papillomatosis with 13-cis-retinoic acid (Accutane) J Biol Response Mod 5 1986 124 128
127. O. Brandli G. Pedio H. Sulser Preliminary results of a six months treatment of bronchial dysplasia in heavy smokers with etretinate III Eur Conf Clin Oncol, Stockholm 1985 61
128. J. Gouveia T. Hercend G. Mathé Degree of bronchial metaplasia in heavy smokers and its regression after treatment with a retinoid Lancet 1 1982 710 712
129. J.L. Misset G. Santelli G. Mathé Regression of bronchial epidermoid metaplasia in heavy smokers with etretinate Cancer Detect Prev 9 1986 167 170
130. P.R. Band M. Deschamps M. Falardeau Treatment of benign breast disease with vitamin A Prev Med 13 1984 549 554
131. V. Graham E.S. Surwit S. Weiner Phase II trial of β-all-trans retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap West J Med 145 1986 192 195
132. E.A. Surwit V. Graham W. Drögemüller Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraepithelial lesions Am J Obstet Gynecol 143 1982 821 823
133. S.A. Weiner E.A. Surwit V.E. Graham A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy Invest New Drugs 4 1986 241 244
134. N.J. Mork P. Jensen P.S. Hoel Vulval lichen sclerosus et atrophicus treated with etretinate (Tigason) Acta Derm Venereol (Stockh) 66 1986 363 365
135. U. Romppanen R. Tuimala J. Ellmén Treatment of dystrophic changes of the vulva with etretinate or placebo Curr Ther Res 42 1987 211 218
136. J.P. Evard W. Bollag Konservative Behandlung der rezidivierenden Harnblasenpapillomatose mit Vitamin A-Säure Schweiz Med Wchnschr 102 1972 1880 1883
137. J. Abrahm E.C. Besa M. Hyzinski Disappearance of cytogenetic abnormalities and clinical remission during therapy with 13-cis-retinoic acid in a patient with myelodysplastic syndrome: Inhibition of growth of the patient's malignant monocytoid clone Blood 67 1986 1323 1327
138. E.C. Besa M. Hyzinski P.C. Nowell Clinical trials and in vitro evaluation of 13-cis-retinoic acid in myelodysplastic syndrome Proc Am Soc Clin Oncol 4 1985 216
139. E.J. Gold R.H. Mertelsmann L.M. Itri Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes Cancer Treat Rep 67 1983 981 986
140. B.R. Greenberg B.G.M. Durie T.C. Barnett Phase I-II study of 13-cis-retinoic acid in myelodysplastic syndrome Cancer Treat Rep 69 1985 1369 1374
141. G. Kerndrup K. Bendix-Hansen B. Pedersen Primary myelodysplastic syndrome: Treatment of 6 patients with 13-cis retinoic acid Scand J Haematol 36 Suppl 45 1986 128 132
142. V.J. Picozi G.F. Swanson R. Morgan 13-cis-Retinoic acid treatment for myelodysplastic syndromes J Clin Oncol 4 1986 589 595
143. B. Berretti C. Grupper Y. Edelson Aromatic retinoid in the treatment of multiple superficial basal cell carcinoma, arsenic keratoses and keratoacanthoma C.E. Orfanos O. Braun-Falco E.M. Farber Retinoids, Advances in Basic Research and Therapy 1981 Springer Berlin 397 1430
144. S.M. Lippman F.L. Meyskens Activity of 13-cis-retinoic acid (Accutane) in advanced squamous cell carcinoma of the skin Ann Intern Med 107 1987 449 501
145. F.L. Meyskens E. Gilmartin D.S. Alberts Activity of isotretinoin against squamous cell cancers and preneoplastic lesions Cancer Treat Rep 66 1982 1315 1319
146. J.E. Fitzpatrick J.R. Mellette Treatment of mycosis fungoides with isotretinoin J Dermatol Surg Oncol 12 1986 626 629
147. J.F. Kessler S.E. Jones N. Levine Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides) Arch Dermatol 123 1987 201 204
148. J.F. Kessler F.L. Meyskens N. Levine Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cisretinoic acid Lancet 1 1983 1345 1347
149. L. Molin K. Thomsen G. Volden 13-cis-Retinoic acid in mycosis fungoides: A report from the Scandinavian Mycosis Fungoides Group J.H. Saurat Retinoids, New Trends in Research and Therapy 1985 Karger Basel 341 1490
150. L. Molin K. Thomsen G. Volden Oral retinoids in mycosis fungoides and Sezary syndrome: A comparison of isotretinoin and etretinate Acta Derm Venereol (Stockh) 67 1987 232 236
151. S.M. Neely M. Mehlmauer D.I. Feinstein The effect of isotretinoin in six patients with cutaneous T-cell lymphoma Arch Intern Med 147 1987 529 531
152. R.P. Warrell C.J. Coonley S.J. Kempin Isotretinoin in cutaneous T-cell lymphoma Lancet 1 1983 629
153. A.L. Claudy B. Rouchouse Treatment of cutaneous T-cell lymphomas with retinoids J.H. Saurat Retinoids, New Trends in Research and Therapy 1985 Karger Basel 335 1530
154. P. Souteyrand J. Thivolet R. Fulton Treatment of parapsoriasis en plaques and mycosis fungoides with an oral aromatic retinoid (Ro 10-9359) C.E. Orfanos O. Braun-Falco E.M. Farber Retinoids, Advances in Basic Research and Therapy 1981 Springer Berlin 313 1540
155. S.M. Lippman J.F. Kessler M. Al-Sarraf Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: A phase II randomized trial Invest New Drugs 6 1988 51 56
156. S.M. Grunberg L.M. Itri Phase II study of isotretinoin in the treatment of advanced non-small cell lung cancer Cancer Treat Rep 71 1987 1097 1098
157. P.J. Flynn W.J. Miller D.J. Weisdorf Retinoic acid treatment of acute promyelocytic leukemia: In vitro and in vivo observations Blood 62 1983 1211 1217
158. H. De Thé C. Chomienne M. Lanoffe The t(15; 17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α gene to a novel transcribed locus Nature 347 1990 558 561
159. P. Chambon Retinoid receptors and binding proteins Haematologica 76 Suppl 4 1991 N46
160. H. De Thé C. Lavau C. Chomienne The t(15; 17) translocation of acute promyelocytic leukemia generates a structurally altered retinoic acid receptor Haematologica 76 Suppl 4 1991 N47
161. P. Kastner A. Perez M.P. Gaub MylRAR and RARMyl fusion transcripts and proteins in acute promyelocytic leukemia (APL) 1991 Retinoids. New Trends in Research and Clinical Applications. Palermo Symposi Palermo, Oct 21–24, 1991, Abstract 23
162. C. Chomienne N. Balitrand P. Ballerini All-trans retinoic acid modulates the retinoic acid receptor-α in promyelocytes J Clin Invest 88 1991 2150 2154
163. H. Zachariae E. Grunnet K. Thestrup-Pedersen Oral retinoid in combination with bleomycin, cyclophosphamide, prednisone and transfer factor in mycosis fungoides Acta Dermatol Venereol (Stockh) 62 1981 162 164
164. H. Zachariae K. Thestrup-Pedersen Combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides: A six-year experience Acta Derm Venereol (Stockh) 67 1987 433 437
165. W. Weber J.P. Obrecht Etretinate, lomustine and bleomycin versus lomustine and bleomycin in advanced squamous cell lung carcinoma Cancer Treat Rep 67 1983 847 849
166. L. Molin K. Thomsen G. Volden Retinoids and systemic chemotherapy in cases of advanced mycosis fungoides A report from the Scandinavian mycosis fungoides group. Acta Derm Venereol (Stockh) 67 1987 179 182
167. L.R. Braathen N. McFadden Successful treatment of mycosis fungoides with combination of etretinate and human recombinant interferon alfa-2a J Dermatol Treatm 1 1989 29 32
168. 2 alone and in combination with etretinate Br J Dermatol 118 1988 811 818
169. H. Zachariae K. Thestrup-Pedersen Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma J Invest Dermatol 95 1990 206 285
170. R.M. Knobler F. Trautinger T. Radaszkiewicz Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa–2b and retinoids J Am Acad Dermatol 24 1991 247 252
171. S.M. Lippman D.R. Parkinson L.M. Itri 13-cis Retinoic acid and interferon α-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin J Natl Cancer Inst 84 1992 235 241
172. S.M. Lippman J.J. Kavanagh M. Paredes-Espinoza 13-cis Retinoic acid plus interferon α-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix J Natl Cancer Inst 84 1992 241 245
173. M. Darmon M. Rocher M.T. Cavey Biological activity of retinoids correlated with affinity for nuclear receptors but not for cytosolic binding protein Skin Pharmacol 1 1988 161 175
174. G. Apfel M. Crettaz P. LeMotte Differential binding and activation of synthetic retinoids to retinoic acid receptors G. Morris-Kay Retinoids in Normal Development and Teratogenesis 1992 Oxford University Press Oxford, New York, Tokyo 65 1740
175. M. Crettaz A. Baron G. Siegenthaler Ligand specificities of recombinant retinoic acid receptors RARα and RARβ Biochem J 272 1990 391 397